Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Biotechnology company Bracco Imaging announced its expansion into the cell-therapy manufacturing space, establishing a new ...

The global photovoltaic (PV) industry is entering a phase defined less by headline capacity additions and more by incremental but compounding improvements in efficiency, reliability, and ...

Few robotics technologies have been actually deployed in high-mix manufacturing. Let's explore the reasons behind this slow ...